👩🍳 How we use AI at Tech in Asia, thoughtfully and responsibly.
🧔♂️ A friendly human may check it before it goes live. More news here
🧔♂️ A friendly human may check it before it goes live. More news here
Israeli healthtech firm raises $8.3m seed funding
Israeli healthtech company Promise Bio has raised US$8.3 million in seed funding to develop its precision medicine platform.
Led by Awz Ventures, the round also saw support from AstraZeneca, Pfizer, and a grant from the Israel Innovation Authority.
The platform uses epiproteomics and AI to predict patient responses to treatments and aid in drug research.
Promise Bio plans to use the funding to accelerate the platform’s development and improve precision medicine for diseases with limited treatment options.
Stay updated on the go with our mobile app.
Get latest insights with smoother, more personalized experience through TIA mobile app.